Skip to content

Entecavir + tenofovir works well for people with hepatitis B who have had prior treatment failure

Micronutrient supplements delay HIV disease progression for patients with higher CD4 cell counts

Early ART only increases TB IRIS risk for people with HIV who have a CD4 cell count below 50

Faldaprevir effective across patient sub-groups with several baseline characteristics associated with treatment outcomes

After diagnosis of hepatitis C, some gay men willing to consider risk-reduction practices

Proportion of people in southern Africa starting ART with advanced HIV disease falls

HIV treatment update – the final edition

HIV treatment update – the final edition

Ritonavir the cause of the interaction between telaprevir and ritonavir-boosted atazanavir

How much longer have I got?